object
evalu
spectrum
comorbid
impact
clinic
outcom
patient
coronaviru
diseas
set
hospit
provinceautonom
regionsprovinci
municip
across
china
particip
laboratoryconfirm
hospit
patient
extract
medic
chart
diseas
sever
categor
base
american
thorac
societi
guidelin
communityacquir
pneumonia
primari
endpoint
composit
endpoint
consist
admiss
intens
care
unit
icu
invas
ventil
death
risk
reach
composit
endpoint
compar
among
patient
accord
presenc
number
comorbid
result
case
mean
age
year
patient
femal
patient
manag
insid
hubei
provinc
patient
contact
histori
wuhan
citi
sever
case
account
studi
popul
patient
reach
composit
endpoint
report
least
one
comorbid
medrxiv
preprint
malign
immunodefici
respect
patient
report
two
comorbid
patient
two
comorbid
significantli
escal
risk
reach
composit
endpoint
compar
singl
comorbid
even
compar
without
p
adjust
age
smoke
statu
patient
copd
hr
ci
diabet
hr
ci
hypertens
hr
ci
malign
hr
ci
like
reach
composit
endpoint
without
compar
patient
without
comorbid
hr
ci
ci
among
patient
least
one
comorbid
ci
among
patient
two
comorbid
comorbid
present
around
one
fourth
patient
china
predispos
poorer
clinic
outcom
fund
support
nation
health
commiss
depart
scienc
technolog
guangdong
provinc
funder
role
conduct
studi
sinc
novemb
rapid
outbreak
coronaviru
diseas
recent
becom
public
health
emerg
intern
concern
laboratoryconfirm
case
death
global
februari
th
previou
studi
demonstr
associ
comorbid
sever
acut
respiratori
diseas
includ
sar
mer
studi
nationwid
repres
cohort
demonstr
spectrum
comorbid
impact
comorbid
clinic
outcom
patient
nationwid
studi
patient
comorbid
identifi
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
sinc
novemb
rapid
outbreak
coronaviru
diseas
aros
sever
acut
respiratori
syndrom
coronaviru
infect
recent
becom
public
health
emerg
intern
concern
contribut
enorm
advers
impact
global
hitherto
laboratoryconfirm
case
death
global
februari
th
clinic
manifest
accord
latest
report
larg
heterogen
admiss
patient
report
least
one
comorbid
diabet
hypertens
cardiovascular
cerebrovascular
diseas
common
previou
studi
demonstr
presenc
comorbid
associ
increas
risk
develop
acut
respiratori
distress
syndrom
patient
infect
similar
influenza
sever
acut
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
readili
predispos
respiratori
failur
death
suscept
patient
nonetheless
previou
studi
certain
limit
studi
design
includ
rel
small
sampl
size
singl
center
observ
studi
address
limit
need
explor
factor
underli
advers
impact
object
compar
clinic
characterist
outcom
patient
stratif
accord
presenc
categori
comorbid
thu
unravel
subpopul
poorer
prognosi
retrospect
cohort
studi
collect
data
patient
throughout
china
coordin
nation
health
commiss
mandat
report
clinic
inform
individu
design
hospit
admit
patient
care
medic
chart
review
compil
clinic
data
laboratoryconfirm
hospit
case
hospit
novemb
st
januari
st
diagnosi
made
base
world
health
organ
interim
guidanc
confirm
case
denot
patient
whose
highthroughput
sequenc
realtim
reversetranscript
polymerasechainreact
rtpcr
assay
find
nasal
pharyng
swab
specimen
posit
see
onlin
supplement
detail
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
clinic
data
includ
recent
exposur
histori
clinic
symptom
sign
comorbid
laboratori
find
upon
admiss
review
extract
experienc
respiratori
clinician
subsequ
enter
data
computer
databas
crosscheck
manifest
chest
xray
comput
tomographi
ct
summar
integr
document
descript
medic
chart
avail
review
medic
staff
major
disagr
radiolog
manifest
two
review
resolv
consult
anoth
independ
review
diseas
sever
reportedli
predict
poorer
clinic
outcom
avian
influenza
patient
classifi
sever
nonsever
base
american
thorac
societi
guidelin
communityacquir
pneumonia
global
accept
comorbid
determin
base
patient
selfreport
admiss
comorbid
initi
treat
categor
variabl
ye
vs
subsequ
classifi
base
number
singl
vs
multipl
furthermor
comorbid
sort
accord
organ
system
ie
respiratori
cardiovascular
endocrin
comorbid
classifi
organ
system
ie
coronari
heart
diseas
hypertens
would
merg
singl
categori
primari
endpoint
studi
composit
measur
consist
admiss
intens
care
unit
icu
invas
ventil
death
composit
measur
adopt
individu
compon
seriou
outcom
infect
secondari
endpoint
mainli
includ
mortal
rate
time
symptom
onset
reach
composit
endpoint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
patient
directli
involv
studi
design
set
research
question
interpret
data
ask
advis
write
report
nation
health
commiss
issu
patient
laboratoryconfirm
china
januari
st
time
point
data
cutoff
databas
includ
case
hospit
provinceautonom
regionsprovinci
municip
see
onlin
supplement
detail
case
mean
age
year
patient
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
femal
patient
manag
insid
hubei
provinc
patient
contact
histori
wuhan
citi
common
symptom
fever
hospit
follow
dri
cough
fatigu
product
cough
less
common
least
one
abnorm
chest
ct
manifest
includ
groundglass
opac
pulmonari
infiltr
interstiti
disord
identifi
patient
sever
case
account
studi
popul
patient
reach
composit
endpoint
studi
tabl
case
report
least
one
comorbid
identifi
patient
report
two
comorbid
two
comorbid
commonli
seen
sever
case
nonsever
case
vs
p
patient
two
comorbid
older
mean
vs
year
like
short
breath
vs
nausea
vomit
vs
unconsci
vs
less
abnorm
chest
xray
vs
compar
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
patient
singl
comorbid
tabl
tabl
composit
endpoint
document
patient
least
one
comorbid
oppos
patient
without
comorbid
p
figur
case
tabl
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
patient
two
comorbid
significantli
escal
risk
reach
composit
endpoint
compar
singl
comorbid
even
compar
without
p
figur
like
reach
composit
endpoint
without
figur
compar
patient
without
comorbid
hr
ci
ci
among
patient
least
one
comorbid
ci
among
patient
two
comorbid
figur
studi
first
nationwid
investig
systemat
evalu
impact
comorbid
clinic
characterist
prognosi
patient
china
circulatori
endocrin
comorbid
common
among
patient
patient
least
one
comorbid
even
associ
poor
clinic
outcom
find
provid
object
evid
larg
sampl
size
extens
coverag
geograph
region
across
china
take
account
baselin
comorbid
diseas
comprehens
risk
assess
prognosi
among
patient
hospit
admiss
overal
find
echo
recent
publish
studi
term
common
comorbid
patient
despit
consider
variat
proport
individu
studi
due
limit
sampl
size
region
patient
manag
circulatori
diseas
includ
hypertens
coronari
heart
diseas
remain
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
except
diabet
comorbid
identifi
predictor
poor
clinic
outcom
patient
merscov
infect
studi
howev
explor
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
consider
overlap
comorbid
wide
accept
instanc
diabet
copd
frequent
coexist
hypertens
coronari
heart
diseas
therefor
patient
coexist
comorbid
like
poorer
baselin
wellb
importantli
verifi
significantli
escal
risk
poor
prognosi
patient
two
comorbid
compar
singl
comorbid
find
impli
categori
number
comorbid
taken
account
predict
prognosi
patient
find
suggest
patient
comorbid
greater
diseas
sever
compar
without
greater
number
comorbid
correl
greater
diseas
sever
public
health
implic
studi
proper
triag
patient
implement
outpati
clinic
hospit
admiss
care
inquir
medic
histori
help
identifi
patient
would
like
develop
seriou
advers
outcom
progress
multidisciplinari
team
specialist
would
need
manag
comorbid
condit
time
fashion
moreov
patient
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
comorbid
isol
immedi
upon
confirm
diagnosi
would
help
provid
suscept
popul
better
person
medic
protect
main
limit
studi
selfreport
comorbid
admiss
underreport
comorbid
could
stem
lack
awar
andor
lack
diagnost
test
might
contribut
underestim
true
strength
associ
clinic
prognosi
howev
signific
underreport
unlik
spectrum
report
larg
consist
exist
literatur
patient
subject
thorough
histori
take
hospit
admiss
moreov
durat
followup
rel
short
patient
remain
hospit
time
write
studi
explor
associ
suffici
long
time
frame
warrant
observ
studi
find
provid
direct
infer
causat
revers
causat
comorbid
poor
clinic
outcom
comorbid
present
around
one
fourth
patient
china
predispos
poorer
clinic
outcom
thorough
assess
comorbid
may
help
establish
risk
stratif
patient
upon
hospit
admiss
thank
hospit
staff
see
supplementari
appendix
full
list
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
common
licencedetail
creativ
common
licenc
appli
research
articl
set
worldwid
licenc
refer
data
bold
indic
statist
comparison
signific
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
data
bold
indic
statist
comparison
signific
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
figur
b
timedepend
risk
reach
composit
endpoint
patient
without
comorbid
orang
curv
patient
singl
comorbid
dark
blue
curv
patient
two
comorbid
green
curv
shown
figur
hazard
ratio
hr
confid
interv
ci
risk
factor
associ
composit
endpoint
admiss
intens
care
unit
invas
ventil
death
comorbid
classifi
accord
organ
system
well
number
scale
bar
indic
hr
model
adjust
age
smoke
statu
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
